174 related articles for article (PubMed ID: 14671469)
1. The impact of reimbursement criteria on the appropriateness of 'statin' prescribing.
Autier P; Creplet J; Vansant G; Brohet C; Paquot N; Muls E; Mullie P; Grivegnée AR
Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):456-62. PubMed ID: 14671469
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypercholesterolemia in patients with diabetes at a family practice office.
Camenga D; Gill JM
Del Med J; 2003 Nov; 75(11):415-20. PubMed ID: 14870630
[TBL] [Abstract][Full Text] [Related]
3. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents.
Dupuy AM; Carrière I; Scali J; Cristol JP; Ritchie K; Dartigues JF; Gambert P; Ancelin ML
Climacteric; 2008 Feb; 11(1):74-83. PubMed ID: 18202967
[TBL] [Abstract][Full Text] [Related]
4. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
Sampalis JS; Bissonnette S; Habib R; Boukas S;
Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
[TBL] [Abstract][Full Text] [Related]
5. A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care.
Kedward J; Dakin L
Br J Gen Pract; 2003 Sep; 53(494):684-9. PubMed ID: 15103875
[TBL] [Abstract][Full Text] [Related]
6. Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'.
Ashworth M; Lloyd D; Smith RS; Wagner A; Rowlands G
J Public Health (Oxf); 2007 Mar; 29(1):40-7. PubMed ID: 17071815
[TBL] [Abstract][Full Text] [Related]
7. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
8. Statin initiation by GPs in WA--a structured vignette study.
Stafford L; Harmer N; Dhaliwal S; Jiwa M
Aust Fam Physician; 2009 Sep; 38(9):739-42. PubMed ID: 19893806
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
[TBL] [Abstract][Full Text] [Related]
10. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Cheng AY; Leiter LA
Curr Opin Cardiol; 2006 Jul; 21(4):400-4. PubMed ID: 16755211
[TBL] [Abstract][Full Text] [Related]
11. [Application of medical guidelines for the prescription of statins].
Chevalier C; Giral P; Chinaud F; Carzon M; Gartenlaub D; Blanchon B; Trutt B
Rev Epidemiol Sante Publique; 2002 Oct; 50(5):463-73. PubMed ID: 12471339
[TBL] [Abstract][Full Text] [Related]
12. The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patients.
Foley KA; Denke MA; Kamal-Bahl S; Simpson R; Berra K; Sajjan S; Alexander CM
Med Care; 2006 May; 44(5):421-8. PubMed ID: 16641660
[TBL] [Abstract][Full Text] [Related]
13. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
[TBL] [Abstract][Full Text] [Related]
14. Frequency of statin use in type 2 diabetics having macrovascular disease- at a Tertiary Care Hospital of Karachi.
Basit A; Hydrie MZ; Hakeem R; Ahmedani MY; Masood Q
J Ayub Med Coll Abbottabad; 2004; 16(4):60-4. PubMed ID: 15762067
[TBL] [Abstract][Full Text] [Related]
15. Achieving target cholesterol levels in diabetic patients: potency of the statin or potency of the physician?
Shani M; Dresner J; Vinker S
Isr Med Assoc J; 2008 May; 10(5):354-7. PubMed ID: 18605358
[TBL] [Abstract][Full Text] [Related]
16. [Lipid control in diabetic patients in Extremadura (Spain)].
Roberto Robles N; Barroso S; Marcos G; Sánchez Muñoz-Torrero JF;
Endocrinol Nutr; 2009 Mar; 56(3):112-7. PubMed ID: 19627723
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trials and recent patterns in the use of statins.
Wang TJ; Stafford RS; Ausiello JC; Chaisson CE
Am Heart J; 2001 Jun; 141(6):957-63. PubMed ID: 11376310
[TBL] [Abstract][Full Text] [Related]
18. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
19. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
20. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
